Show Summary Details
Page of

Biomarker identification and clinical validation 

Biomarker identification and clinical validation
Chapter:
Biomarker identification and clinical validation
Author(s):

Richard D. Kennedy

, Manuel Salto-Tellez

, D. Paul Harkin

, and Patrick G. Johnston

DOI:
10.1093/med/9780199656103.003.0011_update_001

Updates

Table 11.1 updated with two new biomarkers and references. NRAS added.

MSI testing added as example of predictive biomarker in predictive biomarker section.

Language updated under oncotype DX description.

Updated on 29 March 2019. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 October 2019

Most cancer therapy is given in a ‘one size fits all’ manner depending on the anatomical site involved and basic histopathology, with drug dosage calculated from clinical trials using toxicity as an endpoint. An improved understanding of cancer at a molecular level has led clinicians to question how we develop novel drugs and select appropriate patients in the clinic. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers can potentially be used to tailor a patient’s treatment to improve survival and reduce unnecessary toxicity. Though many cancer-related biomarkers have been published in peer-reviewed articles, few have made an impact on patient care because of a failure to demonstrate clinical validity. This chapter explains biomarker discovery and delivery with a view to describing what constitutes a valid biomarker suitable for clinical use.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.